Diplomat Announces COSENTYX® Availability for the Treatment of Two New Indications

Diplomat Announces COSENTYX® Availability for the Treatment of Two New Indications

"The two new approved indications are a real turning point for those living with ankylosing spondylitis and psoriatic arthritis–offering a new approach to treating two of the most common inflammatory joint conditions." COSENTYX® is manufactured by

(Visited 3 times, 1 visits today)
7
Like
Save

Comments

Comments are disabled for this post.